KQB548
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KQB548, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies [Phase 1]